Monheit Law Monheit Law - Personal Injury Attorneys
Risperdal News Log

Risperdal-Help Org.
Blog Home
Archives
Articles

Do I have a Risperdal Case?


Do I have a Strattera Case?


Do I have an Adderall Case?


Listed in LS Blogs


Risperdal-Help Org. : Blog Home : June 2005 : 2005-06-02

ADHD
June 2, 2005 08:19

http://www.pharmaceutical-business-review.com/research.asp?guid=DMHC2093: Introduction The current ADHD market has long been saturated with traditional methylphenidate and amphetamine based drugs, with the only innovations being the development of extended release versions. However, the recent launch of Strattera (atomoxetine) has already shattered the traditional approach to drug therapy, opening the door for the uptake of new novel drug therapies

Highlights The current global ADHD market is worth $2.7m and is expected to reach $3.4m by 2015, driven primarily by the launch of pipeline drugs and the continued growth of Strattera.ADHD

2005-06-01 «  » 2005-06-07

 
Philadelphia Lawyers - Pennsylvania Lawsuits at Monheit Law

Law Offices of Michael Monheit 1368 Barrowdale Road  Rydal, PA  19046
Call Us Toll Free: 866-761-1385  P: 215-840-6573  E: Michael@Monheit.com

AddThis Social Bookmark Button Home  |  Site Map  |  Blogs  |  Do I Have A Case?

© 2002-2010 - Monheit Law, P.C. - Philadelphia PA Personal Injury Law Firm. All rights reserved.
Location:  1368 Barrowdale Road, Jenkintown, PA 19046.  215-840-6573.

Personal Injury Attorney Disclaimer:  This website provides general information about Pennsylvania Personal Injury lawsuits and other legal information. Nothing on this site is intended to be legal advice. The materials on this site may be considered advertising. Nothing on this site constitutes the formation of an attorney client relationship. This website is not intended to solicit clients outside the State of New Jersey or the Commonwealth of Pennsylvania. In order to discuss representation, we must personally speak with you and enter into a signed, written agreement for representation. By utilizing this site, you agree to the foregoing.